{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Amcenestrant",
  "nciThesaurus": {
    "casRegistry": "2114339-57-8",
    "chebiId": "",
    "chemicalFormula": "",
    "definition": "An orally available, nonsteroidal selective estrogen receptor degrader/downregulator (SERD), with potential antineoplastic activity. Upon oral administration, amcenestrant specifically targets and binds to the estrogen receptor (ER) and induces a conformational change that promotes ER degradation. This prevents ER-mediated signaling and inhibits both the growth and survival of ER-expressing cancer cells.",
    "fdaUniiCode": "TBF1NHY02O",
    "identifier": "C174915",
    "preferredName": "Amcenestrant",
    "semanticType": "Pharmacologic Substance",
    "subclassOf": [
      "C2116",
      "C481"
    ],
    "synonyms": [
      "AMCENESTRANT",
      "Amcenestrant",
      "SAR 439859",
      "SAR-439859",
      "SAR439859",
      "Selective Estrogen Receptor Degrader SAR439859",
      "Selective Estrogen Receptor Downregulator SAR439859"
    ]
  }
}